Autoimmune Conditions

  • The Stanford Medicine professor on why it’s important to better understand the microbiome of people transitioning from traditional to Westernized lifestyles.

  • How Epstein-Barr virus triggers multiple sclerosis

    A new study found that part of the Epstein-Barr virus mimics a protein made in the brain and spinal cord, leading the immune system to mistakenly attack the body’s nerve cells.

  • Common genetic profile linked to drug reaction

    New medications help many people with inflammatory conditions and may ease severe COVID-19, but they carry risks.

  • Statins could treat ulcerative colitis

    People with ulcerative colitis who are also taking statins have about a 50% decreased risk of colectomies and hospitalization, according to a Stanford Medicine study.

  • Severe COVID-19, autoantibodies linked

    A study spearheaded by Stanford researchers indicates that at least 1 in 5 hospitalized COVID-19 patients develops new antibodies that attack their own tissue within a week of admission.

  • COVID-19 hospitalizations among kids likely overcounted

    Children being treated in hospitals are tested for SARS-CoV-2, but many who test positive never develop COVID-19 symptoms, leading to overestimates of disease severity, a study found.

  • Biomarker for lipedema discovered

    Researchers have identified a molecule that ties lipedema to other lymphatic diseases, such as lymphedema, and distinguishes it from obesity.

  • Method to regrow cartilage

    In laboratory studies, Stanford School of Medicine researchers have found a way to regenerate the cartilage that eases movement between bones.

  • New center for rare eye disease

    A $10 million gift has enabled the launch of a center focusing on optic disc drusen, a poorly understood eye disease that can lead to visual impairment or even blindness.

  • Microbial loss, ulcerative colitis linked

    Bacteria normally inhabiting healthy people’s intestines — and the anti-inflammatory metabolites these bacteria produce — are depleted in ulcerative colitis patients, a Stanford study shows.

  • Stanford-led teams nab top clinical research prizes

    Winning studies were chosen by members of the Clinical Research Forum, a nonprofit foundation that promotes the understanding of clinical research and its impact on health and health care.

  • New incubator for life science innovation

    A recently vacated building in Stanford Research Park will be the future home of a new life science incubator and lab suites. Located near campus, this incubator will serve as an anchor for a preeminent life science district.